Moderna has downgraded the sales forecasts for its Covid-19 vaccine this year, blaming delays in international shipping and temporary issues related to manufacturing capacity.
莫德纳(Moderna)下调了其新型冠状病毒肺炎（COVID-19，即2019冠状病毒病）疫苗的今年全年销售预测，并将其归咎于国际运输延误和与制造产能相关的暂时问题。
您已阅读9%（258字），剩余91%（2588字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。